# BNC2

## Overview
BNC2, or basonuclin zinc finger protein 2, is a gene that encodes a transcription factor characterized by its zinc finger domains, which are integral to its function in DNA binding and gene regulation. The protein encoded by BNC2 is involved in various biological processes, including skin pigmentation, extracellular matrix regulation, and bone development. It is expressed in multiple tissues such as the epidermis, testis, and kidney, and plays a significant role in epithelial-mesenchymal transition and tissue repair. BNC2's interactions with signaling pathways like the Hippo and TGFβ pathways underscore its importance in cellular processes and its potential as a therapeutic target in conditions such as fibrosis and cancer (Orang2023Basonuclin2; Vanhoutteghem2011Basonuclins; BobowskiGerard2022Functional).

## Structure
The BNC2 gene encodes a protein characterized by its zinc finger domains, which are crucial for its function as a transcription factor. The protein structure includes three pairs of zinc fingers, with the first pair being highly conserved and essential for its function. These zinc fingers follow the Cys2His2 motif, involving two cysteines and two histidines that coordinate a zinc ion, stabilizing the protein's fold and enabling DNA binding (Vanhoutteghem2011Basonuclins; FernandezPrado2019Expanding).

BNC2 is subject to extensive alternative splicing, resulting in numerous isoforms. The human BNC2 gene contains 23 exons and can potentially generate over 90,000 mRNA isoforms and 2000 protein isoforms. The most abundant isoform includes exons 1, 2, 2a, 3, 4, 5, and 6, and contains six zinc fingers (Vanhoutteghem2011Basonuclins). The protein is primarily localized in nuclear speckles, suggesting a role in RNA processing, although a soluble form with diffuse nucleoplasmic distribution may also function in gene transcription (Vanhoutteghem2011Basonuclins).

The BNC2 protein is highly conserved evolutionarily, indicating its importance across species. It is expressed in various tissues, including the epidermis, testis, ovary, kidney, intestine, and uterus, with specific expression in mesenchymal cells and hair follicles (Vanhoutteghem2011Basonuclins).

## Function
BNC2 (basonuclin zinc finger protein 2) is a transcription factor involved in various molecular processes in healthy human cells. It plays a significant role in regulating gene expression, particularly in the context of skin pigmentation. BNC2 expression is higher in melanocytes compared to keratinocytes, indicating its primary role in the melanocytic unit of the epidermis. The gene's expression is modulated by non-coding regulatory elements, such as enhancer elements influenced by specific single nucleotide polymorphisms (SNPs) like rs12350739, which affect chromatin accessibility and transcriptional activity (Visser2014Human).

BNC2 is also implicated in the regulation of the extracellular matrix (ECM) production and degradation, playing a role in epithelial-mesenchymal transition (EMT), a process crucial for tissue patterning and repair. It is expressed in fibroblasts and is involved in collagen regulation, suggesting its function in maintaining tissue structure and function (Orang2023Basonuclin2).

In addition to its role in pigmentation and ECM regulation, BNC2 is involved in bone development, particularly in the multiplication of chondrocytes in the growth plate of long bones, which is essential for proper bone growth (Vanhoutteghem2016The).

## Clinical Significance
The BNC2 gene has been implicated in various diseases and conditions due to mutations or alterations in its expression. In high-grade serous ovarian carcinoma (HGSOC), BNC2 is suggested to function as a putative tumor suppressor gene. Its expression is reduced in HGSOC samples, and this downregulation is associated with increased cell survival after oxidative stress, potentially contributing to cancer progression (Cesaratto2016BNC2). 

BNC2 is also linked to epithelial-mesenchymal transition (EMT) and cancer progression, with high expression levels associated with poor prognosis in various cancers, including ovarian, esophageal, prostate, bladder, liver, skin, uterus, stomach, and lung cancers (Orang2023Basonuclin2). In lung cancer models, BNC2 influences interferon signaling pathways, enhancing the expression of genes that inhibit cancer cell growth (Urgard2017Human).

In developmental contexts, BNC2 mutations are associated with congenital malformations such as hypospadias, where certain missense mutations in the gene are more common in affected individuals (Anna2015Evaluation). BNC2 is also involved in fibrogenesis, with its expression being crucial for myofibroblastic activation in fibrosis, suggesting its potential as a therapeutic target (BobowskiGerard2022Functional).

## Interactions
BNC2, a transcription factor, is involved in various protein interactions that influence its role in cellular processes. It physically interacts with the co-regulator YAP1, a component of the Hippo signaling pathway, as demonstrated through co-immunoprecipitation experiments. This interaction suggests a role for BNC2 in modulating transcriptional activities related to myofibroblastic activation and fibrosis (BobowskiGerard2022Functional). BNC2 also interacts with transcriptional regulators involved in the TGFβ (SMAD) signaling pathway, which are crucial for regulating myofibroblastic activation (BobowskiGerard2022Functional).

In addition to these interactions, BNC2's role in gene regulation is supported by its binding to ECM-related genes such as COL1A1, COL5A1, and LOXL1, indicating its involvement in extracellular matrix production and remodeling (BobowskiGerard2022Functional). The protein's interactions were further explored using Rapid Immunoprecipitation Mass Spectrometry of Endogenous Protein (RIME) in LX2 cells, which identified several proteins interacting with BNC2. These interactions were filtered to focus on human transcriptional regulators, providing insights into BNC2's role in transcriptional regulation (BobowskiGerard2022Functional). These findings highlight BNC2's integrative role in fibrogenic signaling pathways and its potential as a therapeutic target in fibrosis.


## References


[1. (Urgard2017Human) Egon Urgard, Anu Reigo, Eva Reinmaa, Ana Rebane, and Andres Metspalu. Human basonuclin 2 up-regulates a cascade set of interferon-stimulated genes with anti-cancerous properties in a lung cancer model. Cancer Cell International, February 2017. URL: http://dx.doi.org/10.1186/s12935-017-0394-x, doi:10.1186/s12935-017-0394-x. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12935-017-0394-x)

[2. (Vanhoutteghem2016The) Amandine Vanhoutteghem, Brigitte Delhomme, Françoise Hervé, Isabelle Nondier, Jean-Maurice Petit, Masatake Araki, Kimi Araki, and Philippe Djian. The importance of basonuclin 2 in adult mice and its relation to basonuclin 1. Mechanisms of Development, 140:53–73, May 2016. URL: http://dx.doi.org/10.1016/j.mod.2016.02.002, doi:10.1016/j.mod.2016.02.002. This article has 16 citations.](https://doi.org/10.1016/j.mod.2016.02.002)

[3. (Vanhoutteghem2011Basonuclins) Amandine Vanhoutteghem, Cyril Bouche, Anna Maciejewski-Duval, Françoise Hervé, and Philippe Djian. Basonuclins and disco: orthologous zinc finger proteins essential for development in vertebrates and arthropods. Biochimie, 93(2):127–133, February 2011. URL: http://dx.doi.org/10.1016/j.biochi.2010.09.010, doi:10.1016/j.biochi.2010.09.010. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.biochi.2010.09.010)

[4. (FernandezPrado2019Expanding) Raul Fernandez-Prado, Mehmet Kanbay, Alberto Ortiz, and Maria Vanessa Perez-Gomez. Expanding congenital abnormalities of the kidney and urinary tract (cakut) genetics: basonuclin 2 (bnc2) and lower urinary tract obstruction. Annals of Translational Medicine, 7(S6):S226–S226, September 2019. URL: http://dx.doi.org/10.21037/atm.2019.08.73, doi:10.21037/atm.2019.08.73. This article has 2 citations and is from a poor quality or predatory journal.](https://doi.org/10.21037/atm.2019.08.73)

[5. (Visser2014Human) Mijke Visser, Robert-Jan Palstra, and Manfred Kayser. Human skin color is influenced by an intergenic dna polymorphism regulating transcription of the nearby bnc2 pigmentation gene. Human Molecular Genetics, 23(21):5750–5762, June 2014. URL: http://dx.doi.org/10.1093/hmg/ddu289, doi:10.1093/hmg/ddu289. This article has 56 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddu289)

[6. (Cesaratto2016BNC2) Laura Cesaratto, Eleonora Grisard, Michela Coan, Luigi Zandonà, Elena De Mattia, Elena Poletto, Erika Cecchin, Fabio Puglisi, Vincenzo Canzonieri, Maria Teresa Mucignat, Antonella Zucchetto, Gabriele Stocco, Alfonso Colombatti, Milena S Nicoloso, and Riccardo Spizzo. Bnc2 is a putative tumor suppressor gene in high-grade serous ovarian carcinoma and impacts cell survival after oxidative stress. Cell Death &amp; Disease, 7(9):e2374–e2374, September 2016. URL: http://dx.doi.org/10.1038/cddis.2016.278, doi:10.1038/cddis.2016.278. This article has 13 citations.](https://doi.org/10.1038/cddis.2016.278)

[7. (Anna2015Evaluation) Skarin Nordenvall Anna, Cao Jia, and Markljung Ellen. Evaluation of bnc2 as a new candidate gene for hypospadias. Journal of Medical Genetics and Genomics, 7(1):1–6, March 2015. URL: http://dx.doi.org/10.5897/jmgg2015.0078, doi:10.5897/jmgg2015.0078. This article has 0 citations.](https://doi.org/10.5897/jmgg2015.0078)

[8. (Orang2023Basonuclin2) Ayla Orang, B Kate Dredge, Chi Yau Liu, Julie M Bracken, Chun-Hsien Chen, Laura Sourdin, Holly J Whitfield, Rachael Lumb, Sarah T Boyle, Melissa J Davis, Michael S Samuel, Philip A Gregory, Yeesim Khew-Goodall, Gregory J Goodall, Katherine A Pillman, and Cameron P Bracken. Basonuclin-2 regulates extracellular matrix production and degradation. Life Science Alliance, 6(10):e202301984, August 2023. URL: http://dx.doi.org/10.26508/lsa.202301984, doi:10.26508/lsa.202301984. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.26508/lsa.202301984)

[9. (BobowskiGerard2022Functional) Marie Bobowski-Gerard, Clémence Boulet, Francesco P. Zummo, Julie Dubois-Chevalier, Céline Gheeraert, Mohamed Bou Saleh, Jean-Marc Strub, Amaury Farce, Maheul Ploton, Loïc Guille, Jimmy Vandel, Antonino Bongiovanni, Ninon Very, Eloïse Woitrain, Audrey Deprince, Fanny Lalloyer, Eric Bauge, Lise Ferri, Line-Carolle Ntandja-Wandji, Alexia K. Cotte, Corinne Grangette, Emmanuelle Vallez, Sarah Cianférani, Violeta Raverdy, Robert Caiazzo, Viviane Gnemmi, Emmanuelle Leteurtre, Benoit Pourcet, Réjane Paumelle, Kim Ravnskjaer, Guillaume Lassailly, Joel T. Haas, Philippe Mathurin, François Pattou, Laurent Dubuquoy, Bart Staels, Philippe Lefebvre, and Jérôme Eeckhoute. Functional genomics uncovers the transcription factor bnc2 as required for myofibroblastic activation in fibrosis. Nature Communications, September 2022. URL: http://dx.doi.org/10.1038/s41467-022-33063-9, doi:10.1038/s41467-022-33063-9. This article has 19 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-022-33063-9)